Back to Trades
von Halem Carl
Interim CFOCIK 0002146823
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
von Halem Carl, Interim CFO, has filed 1 SEC report (2026), all concentrated in Veraxa Biotech AG - Post de-SPAC (VRXA), totaling $0 in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Aug 20 | VRXA Veraxa Biotech AG - Post de-SPAC | von Halem Carl | Interim CFO | Other | $0 |
1 filing